Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

UFS shines in MBA survey
2006-10-25

Here are Prof Tienie Crous (Dean: Faculty of Economic and Management Sciences at the UFS) and Prof Helena van Zyl (Director of the UFS School of Management) with a copy of the Financial Mail.
Photo: Leonie Bolleurs

UFS shines in MBA survey
According to a recent survey published in the Financial Mail, the MBA programme presented by the School of Management at the University of the Free State (UFS) was rated jointly second best in the country by its graduates in terms of quality and standard.
The UFS MBA Programme was also rated fourth best by its graduates in terms of relevance to their business.

“I am overwhelmed and very proud that the School of Management, although we are a young school and have only been in existence for 7 (seven) years, has been rated so high by our graduandi. The School contributes in a very special way to much-needed business training in central South Africa,” said Prof Helena van Zyl, Director of the UFS School of Management.

“According to the survey, we have the lowest acceptance rate of applicants for the MBA programme, with only 33 students being accepted out of every 100 who apply.  In general, we do not compromise on quality – as stated by our slogan: Be worth more.  Given the quality of the programme, our MBA is very affordable – it offers real value for money,” said Prof van Zyl.

According to Prof van Zyl, the School of Management has had an increase the past 6 (six) months in enquiries from prospective students from Gauteng who are interested in studying the MBA programme.  “They are even prepared to travel to Bloemfontein to attend classes,” she said. 

This year Financial Mail moved away from an overall MBA ranking to a detailed consideration of subject area strengths for each business school in South Africa.  The subject Strategy offered at the UFS School of Management was rated second in the country while the subject Economics also received the same rating.

“The School of Management is the flagship of the Faculty of Economic and Management Sciences.  It gives the UFS and this faculty a standing in corporate South Africa.  This is largely due to Prof Helena van Zyl’s strategy to position the school and making it visible on a national level,” said Prof Tienie Crous, Dean: Faculty of Economic and Management Sciences at the UFS.

According to Prof Crous, the UFS School of Management provides students with opportunities to obtain first-hand experience of how big and successful companies are managed.  “For instance, our MBA students undertake an overseas study tour every year.  This year they visited amongst others the headquarters of Airbus in Toulouse, France and next year they will be visiting the headquarters of Toyota and Yamaha in Japan,” said Prof Crous.

Media release
Issued by: Lacea Loader
Media Representative
Tel:   (051) 401-2584
Cell:  083 645 2454
E-mail:  loaderl.stg@mail.uovs.ac.za
24 October 2006

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept